Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• External beam radiotherapy (EBRT)
• Low-dose rate brachytherapy
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Genetic counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	244	562
Performance Status recorded	57%	73%
PSA completed	3%	3%
Gleason Score completed	N/A	N/A
TNM completed	44%	62%
Stage variable assigned	48%	68%

	Specialist MDT	National
No. of men with disease status determined	394	23477
Percentage of men diagnosed with metastatic disease	18%	17%
No. of men diagnosed with M1 (metastases)	70	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical radiotherapy ()	450
Adjusted percentage of men experiencing at least one GI complication (%)	13%